D-Pharm Ltd. Report issue

For profit Phase 2 Phase 3
Founded: Rehovot Israel (1993)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2005
NCT00190047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

dp-b99 (3 trials)

Drugs in Phase 2 Trials (3)

Key: D-Pharm Ltd. (2) Acquired (1)

alteplase (Activase) (1 trial)

dp-vpa (1 trial)

thr-18 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Ischemia (Phase 2)

Cerebral Infarction (Phase 3)

Cerebrovascular Disorders (Phase 2)

Ischemia (Phase 3)

Migraine Disorders (Phase 2)

Pancreatitis (Phase 2)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4